Update on antibiotics for infection control in cystic fibrosis (Q37608274)

21 August 2017

1 reference

title

Update on antibiotics for infection control in cystic fibrosis (English)

1 reference

21 August 2017

0 references

0 references

Stephen Kirkby

1 reference

21 August 2017

Kimberly Novak

series ordinal

1 reference

21 August 2017

Karen McCoy

series ordinal

1 reference

21 August 2017

publication date

1 October 2009

1 reference

Expert Review of Anti-infective Therapy

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

967-980

1 reference

Cystic fibrosis since 1938.

21 August 2017

cites work

1 reference

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

21 January 2018

1 reference

21 January 2018

1 reference

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

21 January 2018

1 reference

Evolving concepts in biofilm infections

21 January 2018

1 reference

P. aeruginosa Biofilms in CF Infection

21 January 2018

1 reference

Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.

21 January 2018

1 reference

Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis

21 January 2018

1 reference

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis

21 January 2018

1 reference

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

21 January 2018

1 reference

Burkholderia and emerging pathogens in cystic fibrosis

21 January 2018

1 reference

Defining a pulmonary exacerbation in cystic fibrosis

21 January 2018

1 reference

Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior

21 January 2018

1 reference

Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis

21 January 2018

1 reference

Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis.

21 January 2018

1 reference

Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis

21 January 2018

1 reference

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

21 January 2018

1 reference

Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.

21 January 2018

1 reference

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial

21 January 2018

1 reference

Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

21 January 2018

1 reference

Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes

21 January 2018

1 reference

Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis

21 January 2018

1 reference

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience

21 January 2018

1 reference

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

21 January 2018

1 reference

Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome

21 January 2018

1 reference

Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis

21 January 2018

1 reference

Aerosolized antibiotics in cystic fibrosis

21 January 2018

1 reference

Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety

21 January 2018

1 reference

Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells

21 January 2018

1 reference

Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice

21 January 2018

1 reference

Azithromycin increases chloride efflux from cystic fibrosis airway epithelial cells

21 January 2018

1 reference

Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice

21 January 2018

1 reference

Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells

21 January 2018

1 reference

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

Azithromycin for cystic fibrosis

21 January 2018

1 reference

Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis

21 January 2018

1 reference

The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis

21 January 2018

1 reference

Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis

21 January 2018

1 reference

Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis

21 January 2018

1 reference

Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis

21 January 2018

1 reference

Linezolid pharmacokinetics in adult patients with cystic fibrosis

21 January 2018

1 reference

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

21 January 2018

1 reference

Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.

21 January 2018

1 reference

Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid

21 January 2018

1 reference

One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis.

21 January 2018

1 reference

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

21 January 2018

1 reference

Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.

21 January 2018

1 reference

Combination aerosol therapy to treat Burkholderia cepacia complex

21 January 2018

1 reference

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

21 January 2018

1 reference

Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis

21 January 2018

1 reference

Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance

21 January 2018

1 reference

Emerging and unusual gram-negative infections in cystic fibrosis

21 January 2018

1 reference

Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis

21 January 2018

1 reference

Update on the Burkholderia cepacia complex

21 January 2018

1 reference

Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients

21 January 2018

1 reference

Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel

21 January 2018

1 reference

Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

21 January 2018

1 reference

Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease

21 January 2018

1 reference

Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient

21 January 2018

1 reference

Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence

21 January 2018

1 reference

Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis

21 January 2018

1 reference

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

21 January 2018

1 reference

Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.

21 January 2018

1 reference

Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study

21 January 2018

1 reference

Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration

21 January 2018

1 reference

Pilot study of continuous infusion cefepime in adult patients with cystic fibrosis

21 January 2018

1 reference

Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis

21 January 2018

1 reference

Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis

21 January 2018

1 reference

Nanoparticles for drug delivery to the lungs

21 January 2018

1 reference

Microparticles for inhalational delivery of antipseudomonal antibiotics

21 January 2018

1 reference

In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species

21 January 2018

1 reference

Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study.

21 January 2018

1 reference

Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery

21 January 2018

1 reference

Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size

21 January 2018

1 reference

Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.

21 January 2018

1 reference

New advances in aerosolised drug delivery: vibrating membrane nebuliser technology

21 January 2018

1 reference

Strategies for identifying modifier genes in cystic fibrosis

21 January 2018

1 reference

Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease

21 January 2018

1 reference

PTC124 targets genetic disorders caused by nonsense mutations

21 January 2018

1 reference

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

21 January 2018

1 reference

Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis

21 January 2018

1 reference

Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis

21 January 2018

1 reference

Inhalation of Moli1901 in patients with cystic fibrosis.

21 January 2018

1 reference

Epidemiology ofBurkholderia cepaciacomplex colonisation in cystic fibrosis patients

21 January 2018

1 reference

Identification and management of unusual pathogens in cystic fibrosis

21 January 2018

1 reference

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

21 January 2018

1 reference

Lung Function in Infants with Cystic Fibrosis Diagnosed by Newborn Screening

21 January 2018

1 reference

Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.09.82

1 reference

21 August 2017

1 reference